nodes	percent_of_prediction	percent_of_DWPC	metapath
Procaine—BCHE—diaphragm—ovarian cancer	0.0112	0.489	CbGeAlD
Procaine—Anaphylactoid reaction—Topotecan—ovarian cancer	0.01	0.0105	CcSEcCtD
Procaine—Dizziness—Altretamine—ovarian cancer	0.00995	0.0104	CcSEcCtD
Procaine—Vomiting—Altretamine—ovarian cancer	0.00957	0.00999	CcSEcCtD
Procaine—Cardiac arrest—Topotecan—ovarian cancer	0.00921	0.00962	CcSEcCtD
Procaine—Cardiac arrest—Melphalan—ovarian cancer	0.00902	0.00942	CcSEcCtD
Procaine—Nausea—Altretamine—ovarian cancer	0.00894	0.00933	CcSEcCtD
Procaine—Neuropathy peripheral—Chlorambucil—ovarian cancer	0.00822	0.00858	CcSEcCtD
Procaine—Body temperature increased—Carboplatin—ovarian cancer	0.00822	0.00858	CcSEcCtD
Procaine—Atrioventricular block—Paclitaxel—ovarian cancer	0.00791	0.00827	CcSEcCtD
Procaine—Hallucination—Chlorambucil—ovarian cancer	0.00749	0.00782	CcSEcCtD
Procaine—Clomifene—ESR1—ovarian cancer	0.00743	0.382	CrCbGaD
Procaine—Neuropathy peripheral—Topotecan—ovarian cancer	0.00732	0.00764	CcSEcCtD
Procaine—Neuropathy—Paclitaxel—ovarian cancer	0.00721	0.00753	CcSEcCtD
Procaine—Neuropathy peripheral—Melphalan—ovarian cancer	0.00716	0.00748	CcSEcCtD
Procaine—Eruption—Epirubicin—ovarian cancer	0.00714	0.00745	CcSEcCtD
Procaine—Eruption—Doxorubicin—ovarian cancer	0.0066	0.00689	CcSEcCtD
Procaine—Paralysis—Epirubicin—ovarian cancer	0.00632	0.0066	CcSEcCtD
Procaine—Neuropathy peripheral—Vinorelbine—ovarian cancer	0.00626	0.00654	CcSEcCtD
Procaine—Tremor—Chlorambucil—ovarian cancer	0.00614	0.00641	CcSEcCtD
Procaine—Neuropathy—Docetaxel—ovarian cancer	0.00611	0.00638	CcSEcCtD
Procaine—Agitation—Chlorambucil—ovarian cancer	0.00602	0.00629	CcSEcCtD
Procaine—Chills—Topotecan—ovarian cancer	0.00601	0.00628	CcSEcCtD
Procaine—Angioedema—Chlorambucil—ovarian cancer	0.00599	0.00625	CcSEcCtD
Procaine—Ventricular arrhythmia—Epirubicin—ovarian cancer	0.00593	0.00619	CcSEcCtD
Procaine—Dermatitis exfoliative—Paclitaxel—ovarian cancer	0.00591	0.00617	CcSEcCtD
Procaine—Leukopenia—Chlorambucil—ovarian cancer	0.00586	0.00612	CcSEcCtD
Procaine—Paralysis—Doxorubicin—ovarian cancer	0.00585	0.0061	CcSEcCtD
Procaine—Convulsion—Chlorambucil—ovarian cancer	0.00568	0.00593	CcSEcCtD
Procaine—Ventricular arrhythmia—Doxorubicin—ovarian cancer	0.00549	0.00573	CcSEcCtD
Procaine—Angioedema—Topotecan—ovarian cancer	0.00533	0.00557	CcSEcCtD
Procaine—Cardiac arrest—Paclitaxel—ovarian cancer	0.0053	0.00553	CcSEcCtD
Procaine—Thrombocytopenia—Chlorambucil—ovarian cancer	0.00524	0.00547	CcSEcCtD
Procaine—Leukopenia—Topotecan—ovarian cancer	0.00522	0.00545	CcSEcCtD
Procaine—Leukopenia—Melphalan—ovarian cancer	0.00511	0.00534	CcSEcCtD
Procaine—Vasodilation—Epirubicin—ovarian cancer	0.005	0.00522	CcSEcCtD
Procaine—Vasodilation procedure—Epirubicin—ovarian cancer	0.005	0.00522	CcSEcCtD
Procaine—Erythema—Vinorelbine—ovarian cancer	0.00499	0.00521	CcSEcCtD
Procaine—Arthralgia—Topotecan—ovarian cancer	0.00497	0.00519	CcSEcCtD
Procaine—Convulsion—Melphalan—ovarian cancer	0.00495	0.00517	CcSEcCtD
Procaine—Anaphylactic shock—Topotecan—ovarian cancer	0.00476	0.00497	CcSEcCtD
Procaine—Sweating increased—Paclitaxel—ovarian cancer	0.00469	0.0049	CcSEcCtD
Procaine—Oedema—Melphalan—ovarian cancer	0.00466	0.00487	CcSEcCtD
Procaine—Anaphylactic shock—Melphalan—ovarian cancer	0.00466	0.00487	CcSEcCtD
Procaine—Thrombocytopenia—Topotecan—ovarian cancer	0.00466	0.00487	CcSEcCtD
Procaine—Vasodilation procedure—Doxorubicin—ovarian cancer	0.00462	0.00483	CcSEcCtD
Procaine—Vasodilation—Doxorubicin—ovarian cancer	0.00462	0.00483	CcSEcCtD
Procaine—Fatigue—Chlorambucil—ovarian cancer	0.00461	0.00481	CcSEcCtD
Procaine—Hyperhidrosis—Topotecan—ovarian cancer	0.0046	0.00481	CcSEcCtD
Procaine—Thrombocytopenia—Melphalan—ovarian cancer	0.00456	0.00477	CcSEcCtD
Procaine—Angioedema—Vinorelbine—ovarian cancer	0.00456	0.00476	CcSEcCtD
Procaine—Tachycardia—Melphalan—ovarian cancer	0.00455	0.00475	CcSEcCtD
Procaine—Atrioventricular block—Epirubicin—ovarian cancer	0.00453	0.00473	CcSEcCtD
Procaine—Leukopenia—Vinorelbine—ovarian cancer	0.00447	0.00466	CcSEcCtD
Procaine—Hypotension—Melphalan—ovarian cancer	0.00436	0.00455	CcSEcCtD
Procaine—Musculoskeletal discomfort—Topotecan—ovarian cancer	0.00434	0.00453	CcSEcCtD
Procaine—Hypertension—Vinorelbine—ovarian cancer	0.00431	0.0045	CcSEcCtD
Procaine—Urticaria—Chlorambucil—ovarian cancer	0.00425	0.00444	CcSEcCtD
Procaine—Arthralgia—Vinorelbine—ovarian cancer	0.00425	0.00444	CcSEcCtD
Procaine—Musculoskeletal discomfort—Melphalan—ovarian cancer	0.00425	0.00443	CcSEcCtD
Procaine—Body temperature increased—Chlorambucil—ovarian cancer	0.00423	0.00441	CcSEcCtD
Procaine—Neuropathy peripheral—Paclitaxel—ovarian cancer	0.00421	0.0044	CcSEcCtD
Procaine—Atrioventricular block—Doxorubicin—ovarian cancer	0.00419	0.00437	CcSEcCtD
Procaine—Neuropathy—Epirubicin—ovarian cancer	0.00412	0.0043	CcSEcCtD
Procaine—Fatigue—Topotecan—ovarian cancer	0.0041	0.00429	CcSEcCtD
Procaine—Anaphylactic shock—Vinorelbine—ovarian cancer	0.00407	0.00425	CcSEcCtD
Procaine—Fatigue—Melphalan—ovarian cancer	0.00402	0.0042	CcSEcCtD
Procaine—Thrombocytopenia—Vinorelbine—ovarian cancer	0.00399	0.00416	CcSEcCtD
Procaine—Tachycardia—Vinorelbine—ovarian cancer	0.00397	0.00415	CcSEcCtD
Procaine—Hypersensitivity—Chlorambucil—ovarian cancer	0.00394	0.00411	CcSEcCtD
Procaine—Bradycardia—Paclitaxel—ovarian cancer	0.00392	0.0041	CcSEcCtD
Procaine—Neuropathy—Doxorubicin—ovarian cancer	0.00381	0.00398	CcSEcCtD
Procaine—Hypotension—Vinorelbine—ovarian cancer	0.00381	0.00397	CcSEcCtD
Procaine—Pruritus—Chlorambucil—ovarian cancer	0.00378	0.00395	CcSEcCtD
Procaine—Urticaria—Topotecan—ovarian cancer	0.00378	0.00395	CcSEcCtD
Procaine—Body temperature increased—Topotecan—ovarian cancer	0.00376	0.00393	CcSEcCtD
Procaine—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.00371	0.00387	CcSEcCtD
Procaine—Urticaria—Melphalan—ovarian cancer	0.0037	0.00387	CcSEcCtD
Procaine—Diarrhoea—Chlorambucil—ovarian cancer	0.00366	0.00382	CcSEcCtD
Procaine—Tinnitus—Paclitaxel—ovarian cancer	0.00359	0.00375	CcSEcCtD
Procaine—Neuropathy peripheral—Docetaxel—ovarian cancer	0.00357	0.00373	CcSEcCtD
Procaine—Fatigue—Vinorelbine—ovarian cancer	0.00351	0.00367	CcSEcCtD
Procaine—Hypersensitivity—Topotecan—ovarian cancer	0.00351	0.00366	CcSEcCtD
Procaine—Chills—Paclitaxel—ovarian cancer	0.00346	0.00361	CcSEcCtD
Procaine—Hypersensitivity—Melphalan—ovarian cancer	0.00343	0.00359	CcSEcCtD
Procaine—Vomiting—Chlorambucil—ovarian cancer	0.0034	0.00355	CcSEcCtD
Procaine—Dermatitis exfoliative—Epirubicin—ovarian cancer	0.00338	0.00353	CcSEcCtD
Procaine—Pruritus—Topotecan—ovarian cancer	0.00337	0.00352	CcSEcCtD
Procaine—Erythema—Paclitaxel—ovarian cancer	0.00336	0.0035	CcSEcCtD
Procaine—Benzocaine—ABCB1—ovarian cancer	0.00331	0.17	CrCbGaD
Procaine—Pruritus—Melphalan—ovarian cancer	0.0033	0.00344	CcSEcCtD
Procaine—Tension—Paclitaxel—ovarian cancer	0.00329	0.00344	CcSEcCtD
Procaine—Anaphylactoid reaction—Epirubicin—ovarian cancer	0.00329	0.00344	CcSEcCtD
Procaine—Nervousness—Paclitaxel—ovarian cancer	0.00326	0.0034	CcSEcCtD
Procaine—Diarrhoea—Topotecan—ovarian cancer	0.00326	0.0034	CcSEcCtD
Procaine—Urticaria—Vinorelbine—ovarian cancer	0.00324	0.00338	CcSEcCtD
Procaine—Body temperature increased—Vinorelbine—ovarian cancer	0.00322	0.00336	CcSEcCtD
Procaine—Diarrhoea—Melphalan—ovarian cancer	0.00319	0.00333	CcSEcCtD
Procaine—Nausea—Chlorambucil—ovarian cancer	0.00318	0.00332	CcSEcCtD
Procaine—Vision blurred—Paclitaxel—ovarian cancer	0.00316	0.0033	CcSEcCtD
Procaine—Clomifene—ABCB1—ovarian cancer	0.00316	0.162	CrCbGaD
Procaine—Dizziness—Topotecan—ovarian cancer	0.00315	0.00329	CcSEcCtD
Procaine—Tremor—Paclitaxel—ovarian cancer	0.00314	0.00328	CcSEcCtD
Procaine—Dermatitis exfoliative—Doxorubicin—ovarian cancer	0.00312	0.00326	CcSEcCtD
Procaine—Agitation—Paclitaxel—ovarian cancer	0.00308	0.00322	CcSEcCtD
Procaine—Angioedema—Paclitaxel—ovarian cancer	0.00307	0.0032	CcSEcCtD
Procaine—Anaphylactoid reaction—Doxorubicin—ovarian cancer	0.00305	0.00318	CcSEcCtD
Procaine—Cardiac arrest—Epirubicin—ovarian cancer	0.00303	0.00316	CcSEcCtD
Procaine—Vomiting—Topotecan—ovarian cancer	0.00303	0.00316	CcSEcCtD
Procaine—Syncope—Paclitaxel—ovarian cancer	0.00301	0.00314	CcSEcCtD
Procaine—Leukopenia—Paclitaxel—ovarian cancer	0.003	0.00314	CcSEcCtD
Procaine—Rash—Topotecan—ovarian cancer	0.003	0.00313	CcSEcCtD
Procaine—Hypersensitivity—Vinorelbine—ovarian cancer	0.003	0.00313	CcSEcCtD
Procaine—Dermatitis—Topotecan—ovarian cancer	0.003	0.00313	CcSEcCtD
Procaine—Vomiting—Melphalan—ovarian cancer	0.00296	0.00309	CcSEcCtD
Procaine—Loss of consciousness—Paclitaxel—ovarian cancer	0.00295	0.00308	CcSEcCtD
Procaine—Rash—Melphalan—ovarian cancer	0.00294	0.00307	CcSEcCtD
Procaine—Dermatitis—Melphalan—ovarian cancer	0.00294	0.00307	CcSEcCtD
Procaine—Chills—Docetaxel—ovarian cancer	0.00293	0.00306	CcSEcCtD
Procaine—Convulsion—Paclitaxel—ovarian cancer	0.00291	0.00304	CcSEcCtD
Procaine—Hypertension—Paclitaxel—ovarian cancer	0.0029	0.00303	CcSEcCtD
Procaine—Pruritus—Vinorelbine—ovarian cancer	0.00288	0.00301	CcSEcCtD
Procaine—Arthralgia—Paclitaxel—ovarian cancer	0.00286	0.00298	CcSEcCtD
Procaine—Anxiety—Paclitaxel—ovarian cancer	0.00285	0.00297	CcSEcCtD
Procaine—Erythema—Docetaxel—ovarian cancer	0.00284	0.00297	CcSEcCtD
Procaine—Nausea—Topotecan—ovarian cancer	0.00283	0.00295	CcSEcCtD
Procaine—Probenecid—ABCB1—ovarian cancer	0.0028	0.144	CrCbGaD
Procaine—Cardiac arrest—Doxorubicin—ovarian cancer	0.0028	0.00293	CcSEcCtD
Procaine—Diarrhoea—Vinorelbine—ovarian cancer	0.00279	0.00291	CcSEcCtD
Procaine—Nausea—Melphalan—ovarian cancer	0.00277	0.00289	CcSEcCtD
Procaine—Aminohippurate—ABCB1—ovarian cancer	0.00277	0.142	CrCbGaD
Procaine—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00274	0.00286	CcSEcCtD
Procaine—Oedema—Paclitaxel—ovarian cancer	0.00274	0.00286	CcSEcCtD
Procaine—Eosinophilia—Epirubicin—ovarian cancer	0.00273	0.00285	CcSEcCtD
Procaine—Shock—Paclitaxel—ovarian cancer	0.00269	0.00281	CcSEcCtD
Procaine—Dizziness—Vinorelbine—ovarian cancer	0.00269	0.00281	CcSEcCtD
Procaine—Thrombocytopenia—Paclitaxel—ovarian cancer	0.00268	0.0028	CcSEcCtD
Procaine—Tachycardia—Paclitaxel—ovarian cancer	0.00267	0.00279	CcSEcCtD
Procaine—Hyperhidrosis—Paclitaxel—ovarian cancer	0.00265	0.00277	CcSEcCtD
Procaine—Vomiting—Vinorelbine—ovarian cancer	0.00259	0.0027	CcSEcCtD
Procaine—Rash—Vinorelbine—ovarian cancer	0.00257	0.00268	CcSEcCtD
Procaine—Dermatitis—Vinorelbine—ovarian cancer	0.00257	0.00268	CcSEcCtD
Procaine—Hypotension—Paclitaxel—ovarian cancer	0.00256	0.00267	CcSEcCtD
Procaine—Syncope—Docetaxel—ovarian cancer	0.00255	0.00266	CcSEcCtD
Procaine—Leukopenia—Docetaxel—ovarian cancer	0.00255	0.00266	CcSEcCtD
Procaine—Eosinophilia—Doxorubicin—ovarian cancer	0.00252	0.00263	CcSEcCtD
Procaine—Loss of consciousness—Docetaxel—ovarian cancer	0.0025	0.00261	CcSEcCtD
Procaine—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.0025	0.00261	CcSEcCtD
Procaine—Convulsion—Docetaxel—ovarian cancer	0.00246	0.00257	CcSEcCtD
Procaine—Hypertension—Docetaxel—ovarian cancer	0.00246	0.00256	CcSEcCtD
Procaine—Drowsiness—Epirubicin—ovarian cancer	0.00246	0.00256	CcSEcCtD
Procaine—Somnolence—Paclitaxel—ovarian cancer	0.00244	0.00254	CcSEcCtD
Procaine—Arthralgia—Docetaxel—ovarian cancer	0.00242	0.00253	CcSEcCtD
Procaine—Nausea—Vinorelbine—ovarian cancer	0.00242	0.00253	CcSEcCtD
Procaine—Neuropathy peripheral—Epirubicin—ovarian cancer	0.00241	0.00251	CcSEcCtD
Procaine—Fatigue—Paclitaxel—ovarian cancer	0.00236	0.00247	CcSEcCtD
Procaine—Anaphylactic shock—Docetaxel—ovarian cancer	0.00232	0.00242	CcSEcCtD
Procaine—Oedema—Docetaxel—ovarian cancer	0.00232	0.00242	CcSEcCtD
Procaine—Shock—Docetaxel—ovarian cancer	0.00228	0.00239	CcSEcCtD
Procaine—Thrombocytopenia—Docetaxel—ovarian cancer	0.00227	0.00237	CcSEcCtD
Procaine—Drowsiness—Doxorubicin—ovarian cancer	0.00227	0.00237	CcSEcCtD
Procaine—Tachycardia—Docetaxel—ovarian cancer	0.00227	0.00237	CcSEcCtD
Procaine—Bradycardia—Epirubicin—ovarian cancer	0.00224	0.00234	CcSEcCtD
Procaine—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.00223	0.00233	CcSEcCtD
Procaine—GRIN3A—testis—ovarian cancer	0.00221	0.0962	CbGeAlD
Procaine—Urticaria—Paclitaxel—ovarian cancer	0.00218	0.00227	CcSEcCtD
Procaine—Hypotension—Docetaxel—ovarian cancer	0.00217	0.00227	CcSEcCtD
Procaine—Body temperature increased—Paclitaxel—ovarian cancer	0.00217	0.00226	CcSEcCtD
Procaine—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.00212	0.00221	CcSEcCtD
Procaine—Bradycardia—Doxorubicin—ovarian cancer	0.00208	0.00217	CcSEcCtD
Procaine—Somnolence—Docetaxel—ovarian cancer	0.00206	0.00216	CcSEcCtD
Procaine—Tinnitus—Epirubicin—ovarian cancer	0.00206	0.00215	CcSEcCtD
Procaine—Hypersensitivity—Paclitaxel—ovarian cancer	0.00202	0.00211	CcSEcCtD
Procaine—Fatigue—Docetaxel—ovarian cancer	0.002	0.00209	CcSEcCtD
Procaine—Chills—Epirubicin—ovarian cancer	0.00198	0.00207	CcSEcCtD
Procaine—Pruritus—Paclitaxel—ovarian cancer	0.00194	0.00202	CcSEcCtD
Procaine—Erythema—Epirubicin—ovarian cancer	0.00192	0.002	CcSEcCtD
Procaine—Tinnitus—Doxorubicin—ovarian cancer	0.0019	0.00199	CcSEcCtD
Procaine—Tension—Epirubicin—ovarian cancer	0.00188	0.00197	CcSEcCtD
Procaine—Diarrhoea—Paclitaxel—ovarian cancer	0.00187	0.00196	CcSEcCtD
Procaine—Nervousness—Epirubicin—ovarian cancer	0.00186	0.00195	CcSEcCtD
Procaine—Body temperature increased—Docetaxel—ovarian cancer	0.00184	0.00192	CcSEcCtD
Procaine—Chills—Doxorubicin—ovarian cancer	0.00183	0.00191	CcSEcCtD
Procaine—Dizziness—Paclitaxel—ovarian cancer	0.00181	0.00189	CcSEcCtD
Procaine—Vision blurred—Epirubicin—ovarian cancer	0.00181	0.00189	CcSEcCtD
Procaine—Erythema—Doxorubicin—ovarian cancer	0.00178	0.00185	CcSEcCtD
Procaine—Agitation—Epirubicin—ovarian cancer	0.00176	0.00184	CcSEcCtD
Procaine—Tension—Doxorubicin—ovarian cancer	0.00174	0.00182	CcSEcCtD
Procaine—Vomiting—Paclitaxel—ovarian cancer	0.00174	0.00182	CcSEcCtD
Procaine—Rash—Paclitaxel—ovarian cancer	0.00173	0.0018	CcSEcCtD
Procaine—Dermatitis—Paclitaxel—ovarian cancer	0.00173	0.0018	CcSEcCtD
Procaine—Nervousness—Doxorubicin—ovarian cancer	0.00172	0.0018	CcSEcCtD
Procaine—Syncope—Epirubicin—ovarian cancer	0.00172	0.0018	CcSEcCtD
Procaine—Leukopenia—Epirubicin—ovarian cancer	0.00172	0.00179	CcSEcCtD
Procaine—Hypersensitivity—Docetaxel—ovarian cancer	0.00171	0.00179	CcSEcCtD
Procaine—Loss of consciousness—Epirubicin—ovarian cancer	0.00169	0.00176	CcSEcCtD
Procaine—Vision blurred—Doxorubicin—ovarian cancer	0.00167	0.00175	CcSEcCtD
Procaine—Convulsion—Epirubicin—ovarian cancer	0.00166	0.00174	CcSEcCtD
Procaine—Hypertension—Epirubicin—ovarian cancer	0.00166	0.00173	CcSEcCtD
Procaine—Pruritus—Docetaxel—ovarian cancer	0.00164	0.00172	CcSEcCtD
Procaine—Arthralgia—Epirubicin—ovarian cancer	0.00163	0.00171	CcSEcCtD
Procaine—Agitation—Doxorubicin—ovarian cancer	0.00163	0.0017	CcSEcCtD
Procaine—Anxiety—Epirubicin—ovarian cancer	0.00163	0.0017	CcSEcCtD
Procaine—Nausea—Paclitaxel—ovarian cancer	0.00163	0.0017	CcSEcCtD
Procaine—Syncope—Doxorubicin—ovarian cancer	0.00159	0.00166	CcSEcCtD
Procaine—Leukopenia—Doxorubicin—ovarian cancer	0.00159	0.00166	CcSEcCtD
Procaine—Diarrhoea—Docetaxel—ovarian cancer	0.00159	0.00166	CcSEcCtD
Procaine—Anaphylactic shock—Epirubicin—ovarian cancer	0.00157	0.00164	CcSEcCtD
Procaine—Oedema—Epirubicin—ovarian cancer	0.00157	0.00164	CcSEcCtD
Procaine—Loss of consciousness—Doxorubicin—ovarian cancer	0.00156	0.00163	CcSEcCtD
Procaine—Shock—Epirubicin—ovarian cancer	0.00154	0.00161	CcSEcCtD
Procaine—Convulsion—Doxorubicin—ovarian cancer	0.00154	0.00161	CcSEcCtD
Procaine—Dizziness—Docetaxel—ovarian cancer	0.00154	0.0016	CcSEcCtD
Procaine—Thrombocytopenia—Epirubicin—ovarian cancer	0.00153	0.0016	CcSEcCtD
Procaine—Hypertension—Doxorubicin—ovarian cancer	0.00153	0.0016	CcSEcCtD
Procaine—Tachycardia—Epirubicin—ovarian cancer	0.00153	0.0016	CcSEcCtD
Procaine—Hyperhidrosis—Epirubicin—ovarian cancer	0.00151	0.00158	CcSEcCtD
Procaine—Arthralgia—Doxorubicin—ovarian cancer	0.00151	0.00158	CcSEcCtD
Procaine—Anxiety—Doxorubicin—ovarian cancer	0.00151	0.00157	CcSEcCtD
Procaine—Vomiting—Docetaxel—ovarian cancer	0.00148	0.00154	CcSEcCtD
Procaine—Rash—Docetaxel—ovarian cancer	0.00146	0.00153	CcSEcCtD
Procaine—Hypotension—Epirubicin—ovarian cancer	0.00146	0.00153	CcSEcCtD
Procaine—Dermatitis—Docetaxel—ovarian cancer	0.00146	0.00153	CcSEcCtD
Procaine—Anaphylactic shock—Doxorubicin—ovarian cancer	0.00145	0.00151	CcSEcCtD
Procaine—Oedema—Doxorubicin—ovarian cancer	0.00145	0.00151	CcSEcCtD
Procaine—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.00143	0.00149	CcSEcCtD
Procaine—Shock—Doxorubicin—ovarian cancer	0.00143	0.00149	CcSEcCtD
Procaine—Thrombocytopenia—Doxorubicin—ovarian cancer	0.00142	0.00148	CcSEcCtD
Procaine—Tachycardia—Doxorubicin—ovarian cancer	0.00141	0.00148	CcSEcCtD
Procaine—Hyperhidrosis—Doxorubicin—ovarian cancer	0.0014	0.00146	CcSEcCtD
Procaine—Somnolence—Epirubicin—ovarian cancer	0.00139	0.00145	CcSEcCtD
Procaine—Nausea—Docetaxel—ovarian cancer	0.00138	0.00144	CcSEcCtD
Procaine—BCHE—myometrium—ovarian cancer	0.00136	0.0595	CbGeAlD
Procaine—Hypotension—Doxorubicin—ovarian cancer	0.00135	0.00141	CcSEcCtD
Procaine—Fatigue—Epirubicin—ovarian cancer	0.00135	0.00141	CcSEcCtD
Procaine—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.00132	0.00138	CcSEcCtD
Procaine—Somnolence—Doxorubicin—ovarian cancer	0.00129	0.00135	CcSEcCtD
Procaine—Fatigue—Doxorubicin—ovarian cancer	0.00125	0.0013	CcSEcCtD
Procaine—Urticaria—Epirubicin—ovarian cancer	0.00124	0.0013	CcSEcCtD
Procaine—Body temperature increased—Epirubicin—ovarian cancer	0.00124	0.00129	CcSEcCtD
Procaine—Hypersensitivity—Epirubicin—ovarian cancer	0.00115	0.0012	CcSEcCtD
Procaine—Urticaria—Doxorubicin—ovarian cancer	0.00115	0.0012	CcSEcCtD
Procaine—Body temperature increased—Doxorubicin—ovarian cancer	0.00115	0.0012	CcSEcCtD
Procaine—Pruritus—Epirubicin—ovarian cancer	0.00111	0.00116	CcSEcCtD
Procaine—Diarrhoea—Epirubicin—ovarian cancer	0.00107	0.00112	CcSEcCtD
Procaine—Hypersensitivity—Doxorubicin—ovarian cancer	0.00107	0.00111	CcSEcCtD
Procaine—BCHE—uterine cervix—ovarian cancer	0.00106	0.0463	CbGeAlD
Procaine—Dizziness—Epirubicin—ovarian cancer	0.00104	0.00108	CcSEcCtD
Procaine—Pruritus—Doxorubicin—ovarian cancer	0.00103	0.00107	CcSEcCtD
Procaine—Vomiting—Epirubicin—ovarian cancer	0.000996	0.00104	CcSEcCtD
Procaine—Diarrhoea—Doxorubicin—ovarian cancer	0.000991	0.00104	CcSEcCtD
Procaine—Rash—Epirubicin—ovarian cancer	0.000987	0.00103	CcSEcCtD
Procaine—Dermatitis—Epirubicin—ovarian cancer	0.000986	0.00103	CcSEcCtD
Procaine—SLC6A3—testis—ovarian cancer	0.000962	0.042	CbGeAlD
Procaine—BCHE—endometrium—ovarian cancer	0.00096	0.0419	CbGeAlD
Procaine—Dizziness—Doxorubicin—ovarian cancer	0.000958	0.001	CcSEcCtD
Procaine—Nausea—Epirubicin—ovarian cancer	0.00093	0.000971	CcSEcCtD
Procaine—Vomiting—Doxorubicin—ovarian cancer	0.000921	0.000962	CcSEcCtD
Procaine—Rash—Doxorubicin—ovarian cancer	0.000914	0.000954	CcSEcCtD
Procaine—Dermatitis—Doxorubicin—ovarian cancer	0.000913	0.000953	CcSEcCtD
Procaine—SCN10A—lymph node—ovarian cancer	0.000904	0.0394	CbGeAlD
Procaine—BCHE—uterus—ovarian cancer	0.000885	0.0386	CbGeAlD
Procaine—Nausea—Doxorubicin—ovarian cancer	0.000861	0.000899	CcSEcCtD
Procaine—BCHE—female reproductive system—ovarian cancer	0.000795	0.0347	CbGeAlD
Procaine—BCHE—bone marrow—ovarian cancer	0.000751	0.0327	CbGeAlD
Procaine—BCHE—vagina—ovarian cancer	0.000719	0.0314	CbGeAlD
Procaine—BCHE—testis—ovarian cancer	0.000642	0.028	CbGeAlD
Procaine—BCHE—lymph node—ovarian cancer	0.000465	0.0203	CbGeAlD
